Cerebrolysin REGistry Study in Stroke A Registry Study to Assess Practices, Safety and Effectiveness of Cerebrolysin in Routine Treatment of Acute Ischemic Stroke

Trial Profile

Cerebrolysin REGistry Study in Stroke A Registry Study to Assess Practices, Safety and Effectiveness of Cerebrolysin in Routine Treatment of Acute Ischemic Stroke

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 Sep 2017

At a glance

  • Drugs Brain extract (Primary)
  • Indications Stroke
  • Focus Therapeutic Use
  • Acronyms CREGS-S
  • Sponsors EVER Neuro Pharma
  • Most Recent Events

    • 07 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top